Synokem Pharma Gets CDSCO Panel Nod to Study Dydrogesterone SR Tablet
New Delhi: The drug major Synokem Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standa…
Lorem Ipsum has been the industry's standard dummy text.
New Delhi: The drug major Synokem Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standa…
A deeper understanding of how obesity, diabetes, chronic kidney disease, and cardiovascular disease are interconnected has paved the way for a new c…
A combination treatment approach with gemcitabine, cisplatin, and nivolumab in muscle-invasive bladder cancer (MIBC) patients resulted in a clinical…
United States: The U.S. health regulator did not find any misconduct at clinical sites managed by Care Access for Pfizer and French partner Valneva…
New Delhi: The drug major Akum Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard …
A recent study conducted on rats has shed light on the therapeutic potential of psilocybin microdosing, offering new hope for individuals struggling…
New Delhi: The National Medical Commission (NMC) has recently asked medical institutes across the country to submit the details of the students who…
Lorem Ipsum is simply dummy text of the printing and typesetting has been the industry's.